## Abstract The effect of β‐cryptoxanthin, a kind of carotenoid, on cell differentiation and mineralization in osteoblastic MC3T3‐E1 cells was investigated. Cells were cultured for 72 h in a minimum essential medium containing 10% fetal bovine serum (FBS), and the cells with subconfluency were chan
Suppressive effect of regucalcin on cell differentiation and mineralization in osteoblastic MC3T3-E1 cells
✍ Scribed by Masayoshi Yamaguchi; Mayumi Kobayashi; Satoshi Uchiyama
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 301 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The role of regucalcin in the regulation of osteoblastic cell function was investigated. Osteoblastic MC3T3‐E1 cells with subconfluent monolayers were cultured in a medium containing regucalcin (10^−10^–10^−8^ M) without fetal bovine serum (FBS). The proliferation of osteoblastic cells was not significantly altered in the presence of regucalcin. The results of reverse transcription‐polymerase chain reaction (RT‐PCR) analysis with specific primers showed that the expression of Runx2 (Cbfa1) and insulin‐like growth factor‐I (IGF‐I) mRNAs in osteoblastic cells was significantly suppressed in the presence of regucalcin (10^−10^ or 10^−9^ M). Transforming growth factor‐β1 mRNA levels were significantly enhanced in the 24 h‐culture with regucalcin (10^−10^ or 10^−9^ M). α1(I) collagen and glyceroaldehyde‐3‐phosphate dehydrogenase (G3PDH) mRNA levels were not significantly changed by culture with regucalcin (10^−10^ or 10^−9^ M). Alkaline phosphatase activity was significantly decreased in the lysate of cells cultured for 24 or 48 h with regucalcin (10^−10^–10^−8^ M). Moreover, the expression of regucalcin in osteoblastic cells was demonstrated by RT‐PCR and Western blot analysis. When regucalcin (10^−7^ M) was added into the enzyme reaction mixture containing the lysate of osteoblastic cells cultured in the absence of regucalcin, alkaline phosphatase activity was significantly decreased. Also, Ca^2+^/calmodulin‐dependent nitric oxide (NO) synthase activity in the cell lysate was significantly decreased by addition of regucalcin (10^−10^–10^−8^ M) into the reaction mixture. The presence of anti‐regucalcin monoclonal antibody (5 or 10 ng/ml) in the enzyme reaction mixture caused a significant increase in NO synthase activity in the cell lysate in the presence or absence of Ca^2+^/calmodulin, suggesting a role of endogenous regucalcin. When osteoblastic cells with subconfluency were cultured in the presence of regucalcin (10^−10^ or 10^−9^ M) for 3, 9, or 18 days, the results with Alizarin red staining showed that the mineralization was markedly suppressed by culture with regucalcin for 3, 9, or 18 days. This study demonstrates that regucalcin regulates the function of osteoblastic cells, and that the protein suppresses cell differentiation and mineralization. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Hydroxyapatite describes both the natural mineral phase of bone as well as the widely used calcium–phosphate implant substitute. Given that hydroxyapatite is a major component of the __in vivo__ surface with which osteoblasts interact, it is surprising that most studies examining the re
## Abstract Statins inhibit 3‐hydroxy‐3‐methylglutaryl‐coenzyme A (HMG‐CoA) reductase, which catalyzes conversion of HMG‐CoA to mevalonate, a rate‐limiting step in cholesterol synthesis. The present study was undertaken to understand the events of osteoblast differentiation induced by statins. Simv
## Abstract Orthopedic wear debris has been implicated as a significant inhibitory factor of osteoblast differentiation. Polymethylmethacrylate (PMMA) particles have been previously shown to inhibit the differentiation of osteoprogenitors in heterogeneous murine marrow stromal cell cultures, but th
## Abstract The orphan nuclear receptor Nurr1 is primarily expressed in the central nervous system. It has been shown that Nurr1 is necessary for terminal differentiation of dopaminergic (DA) neurons in ventral midbrain. The receptor, however, is also expressed in other organs including bone, even